{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibcd37sek2423uvl4mby7zyovodaplgi7gv4gpaizjppsd5rf7tiy",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mlniepqi2vs2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidjayqrhwixllk56wwolekxztmboagb4thulq43bvgmdeocutqfge"
    },
    "mimeType": "image/jpeg",
    "size": 236364
  },
  "path": "/news/2026-05-personalized-vaccine-aggressive-brain-cancer.html",
  "publishedAt": "2026-05-12T05:00:06.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people in the U.S., is safe and elicits robust and broad immune responses that appear to increase recurrence-free survival in a subset of patients after surgery, according to an early-stage clinical trial co-led by researchers at Washington University School of Medicine in St. Louis.",
  "title": "Personalized vaccine shows promise against aggressive brain cancer"
}